We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Pharmaceuticals » GMPs

GMPs
GMPs RSS Feed RSS

USP and Phlow Partner to Validate Continuous Manufacturing Processes

December 15, 2022
Under the terms of the agreement, the methods that will come out of this partnership will be made available to other domestic generics manufacturers. Read More

FDA Classifies Glenmark Inspection as Official Action Indicated

October 28, 2022
Glenmark said it will engage with the FDA to resolve the deficiencies observed during the inspection. Read More

Takeda to Spend $300 Million to Expand Biotech Manufacturing Site

September 15, 2022
The investment is the largest to date for Takeda in Belgium. Read More

Orca Bio to Build Facility to Manufacture 3,000 Cell Therapy Products Annually

September 9, 2022
The new plant is expected to be operational in the first half of 2023. Read More

Aurobindo’s CuraTeQ to Expand Manufacturing Operations via New $37M Facility

September 8, 2022
The new site is likely to be up and running by 2026. Read More

Bavarian Nordic to Outsource Its Vaccine Supply

August 19, 2022
To stretch the available doses, the FDA issued an emergency authorization that allows for a one-fifth dose to be administered beneath the top layer of the skin. Read More

Pfizer-BioNTech to Deliver Omicron-Adapted Vaccines in October

August 9, 2022
A bivalent vaccine has not yet been approved by the FDA. Read More

FDA Greenlights Jynneos Monkeypox Vaccine for Additional Manufacturing

July 29, 2022
U.S. distribution is expected to begin shortly. Read More

Pfizer to Spend $470 Million in Expansion of Vaccine Research Facilities

July 25, 2022
The facility will continue research into the messenger RNA technology that underpins the Pfizer-BioNTech COVID-19 vaccine. Read More

Bavarian Nordic’s Danish Manufacturing Plant FDA-Inspected for Jynneos Monkeypox Vaccines

July 15, 2022
The U.S. has a limited supply of the Jynneos vaccine. Read More

FDA Review of Santhera’s Vamorolone NDA Delayed Due to Manufacturing Standards

July 5, 2022
The FDA has granted vamorolone Orphan Drug status, as well as Fast Track and Rare Pediatric Disease designations. Read More

Verrica Draws Second Complete Response Letter for Manufacturing Deficiencies

May 26, 2022
West Chester, Pa.-based Verrica Pharmaceuticals drew a second Complete Response Letter (CRL) from the FDA rejecting the company’s New Drug Application (NDA) for its investigational drug VP-102 to treat patients with the viral skin disease molluscum contagiosum. Read More
Previous 1 2 3 4 5 6 7 8 9 … 60 61 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • MedTrace Receives U.S. Patent for Heart Modeling Method

  • NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures

  • Consortium Gets EU Funding to Develop Continuous Blood Pressure Monitoring Device

  • FDA Approves GSK’s Oral Drug for Chronic Kidney Disease-Related Anemia

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing